Israel coronavirus vaccine status
The Israel Institute for Biological Research has claimed it had completed successful coronavirus vaccine trials on rodents, according to a report in The Times of Israel.
Researchers said they hope to have a finished vaccine in a year, or possibly even earlier.
The vaccine, which was tested on hamsters, “results in rapid and potent induction of neutralizing antibodies against SARS-CoV-2”, the report said.
“Importantly, single-dose vaccination was able to protect hamsters against SARS-CoV-2 challenge, as demonstrated by the abrogation of body weight loss of the immunized hamsters compared to unvaccinated hamsters,” researchers wrote in the report.
While the lungs of infected hamsters showed extensive tissue damage and a high viral load, the report said that those given the vaccine “showed only minor lung pathology” and had no viral titre.
MMR coronavirus vaccine status
US researchers have claimed that the measles, mumps and rubella (MMR) vaccine might offer extra protection against Covid-19 and proposed conducting of clinical trials.
In a paper published in mBio, the researchers suggested that the MMR vaccine could help reduce septic inflammation associated with Covid-19 infection.
“A clinical trial with MMR in high-risk populations may provide a low-risk-high-reward preventive measure in saving lives during the Covid-19 pandemic,” said Dr Paul Fidel, Associate Dean for Research at Louisiana State University Health Sc